Selcuk Ecza stock faces scrutiny after CMB trading measures
Published on 11/09/2026 at 03:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRegulatory measures affect trading context
- Turkey's Capital Markets Board imposed trading bans and filed criminal complaints linked to transactions in Selcuk Ecza shares.
- Selcuk Ecza said the measures did not target the company, its board, executives, or employees.
- The regulatory action adds scrutiny to the trading environment around the pharmaceutical distributor.
Turkey's Capital Markets Board filed criminal complaints and imposed trading bans linked to transactions in Selcuk Ecza shares, according to a Reuters brief published by Stockopedia. The report was published on Wednesday, October 28, 2026.
Company says sanctions do not target it
The measures concern transactions conducted in the market for Selcuk Ecza shares. The company said the Capital Markets Board's bulletin contained no criminal complaint or sanction against Selcuk Ecza as a legal entity, its board members, executives, or employees.
The distinction matters for investors: regulatory action connected with trading in a listed company's shares does not by itself establish wrongdoing by the issuer. Any criminal liability remains subject to the relevant proceedings.
Stock quote reflects latest session
Selcuk Ecza stock traded at TRY 73.55 on Borsa Istanbul at 5:08:41 p.m. CET on Friday, November 6, 2026. The pharmaceutical distributor operates in Turkey's healthcare supply chain, with its corporate website describing Selcuk Ecza as a healthcare depot and providing investor-relations material.
Selcuk Ecza stock at a glance
- Company: Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
- ISIN: TRESLEC00014
- Ticker: SELEC.IS
- Exchange: Borsa Istanbul
- Latest quote: TRY 73.55 on November 6, 2026 at 5:08:41 p.m. CET
- Sector: Healthcare
- Industry: Pharmaceuticals
Turkey's BIST 100 provides the broader market context for Selcuk Ecza stock.
